Tesamorelin
Tesamorelin (INN; trade name Egrifta SV) is a synt

hetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy, approved initially in 2010. It is produced and developed by Theratechnologies, Inc. of Canada. The drug is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group.
Chemical Properties
| CAS Number | 901758-09-6 |
|---|---|
| PubChem CID | 44147413 |
| Molecular Weight | 5196g/mol |
| Molecular Formula | C223H370N72O69S |
| Synonyms | UNII-LGW5H38VE3, Tesamorelin Acetate |
| Storage (Lyophilized) | At 39 Fahrenheit: 2 years At -4 Fahrenheit: 3 years |







Reviews
There are no reviews yet.